NO20023770L - Indol-3-ylderivater - Google Patents

Indol-3-ylderivater

Info

Publication number: NO20023770L
Authority: NO; Norway
Prior art keywords: indole; derivatives
Prior art date: 2000-02-11

Application number

NO20023770A

Other languages

English (en)

Other versions

NO20023770D0 (no

Inventor

Simon Goodman

Rudolf Gottschlich

Matthias Wiesner

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-11

Filing date

2002-08-09

Publication date

2002-08-09

2002-08-09 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2002-08-09 Publication of NO20023770D0 publication Critical patent/NO20023770D0/no

2002-08-09 Publication of NO20023770L publication Critical patent/NO20023770L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

NO20023770A 2000-02-11 2002-08-09 Indol-3-ylderivater NO20023770L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10006139A DE10006139A1 (de)	2000-02-11	2000-02-11	Indol-3-yl-Derivate
PCT/EP2001/000084 WO2001058893A2 (de)	2000-02-11	2001-01-05	Indol-3-yl-derivate und deren verwendung als integrin-inhibitoren

Publications (2)

Publication Number	Publication Date
NO20023770D0 NO20023770D0 (no)	2002-08-09
NO20023770L true NO20023770L (no)	2002-08-09

Family

ID=7630611

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023770A NO20023770L (no)	2000-02-11	2002-08-09	Indol-3-ylderivater

Country Status (27)

Country	Link
US (1)	US6743810B2 (no)
EP (1)	EP1254133B9 (no)
JP (1)	JP4938194B2 (no)
KR (1)	KR20020073585A (no)
CN (1)	CN1214026C (no)
AR (1)	AR027398A1 (no)
AT (1)	ATE293620T1 (no)
AU (2)	AU2001231664C1 (no)
BR (1)	BR0108154A (no)
CA (1)	CA2399813C (no)
CO (1)	CO5261548A1 (no)
CZ (1)	CZ20022616A3 (no)
DE (2)	DE10006139A1 (no)
EC (1)	ECSP013923A (no)
ES (1)	ES2240400T3 (no)
HU (1)	HUP0302671A2 (no)
IL (1)	IL151154A0 (no)
MX (1)	MXPA02007732A (no)
NO (1)	NO20023770L (no)
NZ (1)	NZ521260A (no)
PE (1)	PE20011125A1 (no)
PL (1)	PL356427A1 (no)
PT (1)	PT1254133E (no)
RU (1)	RU2257380C2 (no)
SK (1)	SK11152002A3 (no)
WO (1)	WO2001058893A2 (no)
ZA (1)	ZA200207273B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040063790A1 (en) *	1996-05-31	2004-04-01	The Scripps Research Institute	Methods for inhibition of angiogenesis
US20040138284A1 (en) *	2000-02-11	2004-07-15	Matthias Wiesner	Indol-3-yl derivatives
CA2419255A1 (en) *	2000-08-29	2002-03-07	Ish Kumar Khanna	Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
DK1381382T3 (da) *	2000-11-01	2009-02-02	Merck Patent Gmbh	Fremgangsmåder og præparater til behandling af öjensygdomme
GB0028367D0 (en) *	2000-11-21	2001-01-03	Celltech Chiroscience Ltd	Chemical compounds
US6855722B2 (en) *	2001-01-29	2005-02-15	Dimensional Pharmaceuticals, Inc.	Substituted indoles and their use as integrin antagonists
US6872730B2 (en)	2001-04-27	2005-03-29	3-Dimensional Pharmaceuticals, Inc.	Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
RU2311177C2 (ru)	2001-08-01	2007-11-27	Мерк Патент Гмбх	Ингибиторы интегрина для лечения заболевания глаз
EP1474162A1 (en) *	2002-02-14	2004-11-10	MERCK PATENT GmbH	Methods and compositions for the treatment of eye diseases
MXPA05001536A (es) *	2002-08-30	2005-04-19	Eisai Co Ltd	Derivados aromaticos que contienen nitrogeno.
WO2004092130A2 (en) *	2003-04-07	2004-10-28	Kalypsys, Inc.	N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
US7592361B2 (en) *	2003-04-28	2009-09-22	Bayer Pharmaceuticals Corporation	Indole acetic acid derivatives and their use as pharmaceutical agents
US7211588B2 (en)	2003-07-25	2007-05-01	Zentaris Gmbh	N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
DE10337863A1 (de) *	2003-08-18	2005-03-17	Merck Patent Gmbh	Verwendung von Chromen-4-on-Derivaten
DE602004014795D1 (de) *	2003-10-01	2008-08-14	Merck Patent Gmbh	Alfavbeta3 und alfavbeta6 integrin antagonisten als antifibrotische mittel
JP2007536344A (ja) *	2004-05-04	2007-12-13	ノボ　ノルディスク　アクティーゼルスカブ	新規のインドール誘導体
WO2006053342A2 (en) *	2004-11-12	2006-05-18	Osi Pharmaceuticals, Inc.	Integrin antagonists useful as anticancer agents
EP1676834A1 (en) *	2004-12-30	2006-07-05	Sanofi-Aventis Deutschland GmbH	Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
WO2007024294A2 (en) *	2005-05-03	2007-03-01	Cgi Pharmaceuticals, Inc.	Certain substituted ureas, as modulators of kinase activity
CN102335168B (zh) *	2011-10-25	2014-04-02	合肥博太医药生物技术发展有限公司	吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗骨质疏松药物中的应用
AR094812A1 (es) *	2013-02-20	2015-08-26	Eisai R&D Man Co Ltd	Derivado de piridina monocíclico como inhibidor del fgfr
ES2914072T3 (es)	2014-08-18	2022-06-07	Eisai R&D Man Co Ltd	Sal de derivado de piridina monocíclico y su cristal
EP3275442B1 (en)	2015-03-25	2021-07-28	National Cancer Center	Therapeutic agent for bile duct cancer
RU2730503C2 (ru)	2015-12-17	2020-08-24	Эйсай Ар Энд Ди Менеджмент Ко., Лтд.	Терапевтическое средство для лечения рака молочной железы
EP3777860A4 (en)	2018-03-28	2021-12-15	Eisai R&D Management Co., Ltd.	THERAPEUTIC FOR HEPATOCELLULAR CARCINOMA

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT290523B (de) *	1962-01-05	1971-06-11	Merck & Co Inc	Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
GB1148909A (en) *	1965-04-19	1969-04-16	Sumitomo Chemical Co	Process for production of novel phenylhydrazone and phenylhydrazine derivatives
US4824850A (en) *	1982-05-18	1989-04-25	University Of Florida	Brain-specific drug delivery
US4983615A (en) *	1989-06-28	1991-01-08	Hoechst-Roussel Pharmaceuticals Inc.	Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
IL100091A (en) *	1990-12-12	1998-08-16	Zeneca Ltd	Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
IT1244548B (it) *	1991-02-06	1994-07-15	Poli Ind Chimica Spa	Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
GB9225141D0 (en) *	1992-12-01	1993-01-20	Smithkline Beecham Corp	Chemical compounds
WO1997037655A1 (en)	1996-04-10	1997-10-16	Merck & Co., Inc.	αvβ3 ANTAGONISTS
AU4091697A (en) *	1996-08-27	1998-03-19	American Home Products Corporation	4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands
AU1687699A (en) *	1997-12-25	1999-07-19	Yamanouchi Pharmaceutical Co., Ltd.	Nitrogenous heterocyclic derivatives
DK1056452T3 (da) *	1998-02-23	2006-11-20	Univ South Alabama	Indol-3-propionsyre, salte og estere deraf anvendt som medikamenter
CA2322162A1 (en) *	1998-02-25	1999-09-02	Genetics Institute, Llc	Inhibitors of phospholipase enzymes
JP2002510675A (ja) *	1998-04-08	2002-04-09	アメリカン・ホーム・プロダクツ・コーポレイション	うつ病治療用のｎ−アリールオキシエチル−インドリル−アルキルアミン（５−ｈｔ１ａ受容体活性薬）
EP1068184B1 (en) *	1998-04-08	2002-09-04	Wyeth	N-aryloxyethylamine derivatives for the treatment of depression
JP4425699B2 (ja) *	2004-05-17	2010-03-03	川崎重工業株式会社	小型滑走艇

2000
- 2000-02-11 DE DE10006139A patent/DE10006139A1/de not_active Withdrawn
2001
- 2001-01-05 PT PT01903624T patent/PT1254133E/pt unknown
- 2001-01-05 NZ NZ521260A patent/NZ521260A/en unknown
- 2001-01-05 MX MXPA02007732A patent/MXPA02007732A/es unknown
- 2001-01-05 CZ CZ20022616A patent/CZ20022616A3/cs unknown
- 2001-01-05 AU AU2001231664A patent/AU2001231664C1/en not_active Ceased
- 2001-01-05 AT AT01903624T patent/ATE293620T1/de not_active IP Right Cessation
- 2001-01-05 SK SK1115-2002A patent/SK11152002A3/sk not_active Application Discontinuation
- 2001-01-05 WO PCT/EP2001/000084 patent/WO2001058893A2/de not_active Ceased
- 2001-01-05 CN CNB018046703A patent/CN1214026C/zh not_active Expired - Fee Related
- 2001-01-05 IL IL15115401A patent/IL151154A0/xx unknown
- 2001-01-05 DE DE50105955T patent/DE50105955D1/de not_active Expired - Lifetime
- 2001-01-05 PL PL01356427A patent/PL356427A1/xx unknown
- 2001-01-05 HU HU0302671A patent/HUP0302671A2/hu unknown
- 2001-01-05 ES ES01903624T patent/ES2240400T3/es not_active Expired - Lifetime
- 2001-01-05 BR BR0108154-3A patent/BR0108154A/pt not_active IP Right Cessation
- 2001-01-05 AU AU3166401A patent/AU3166401A/xx active Pending
- 2001-01-05 CA CA002399813A patent/CA2399813C/en not_active Expired - Fee Related
- 2001-01-05 RU RU2002123332/04A patent/RU2257380C2/ru not_active IP Right Cessation
- 2001-01-05 EP EP01903624A patent/EP1254133B9/de not_active Expired - Lifetime
- 2001-01-05 KR KR1020027010302A patent/KR20020073585A/ko not_active Withdrawn
- 2001-01-05 US US10/203,406 patent/US6743810B2/en not_active Expired - Fee Related
- 2001-01-05 JP JP2001558443A patent/JP4938194B2/ja not_active Expired - Fee Related
- 2001-02-09 EC EC2001003923A patent/ECSP013923A/es unknown
- 2001-02-09 PE PE2001000143A patent/PE20011125A1/es not_active Application Discontinuation
- 2001-02-09 CO CO01009901A patent/CO5261548A1/es not_active Application Discontinuation
- 2001-02-09 AR ARP010100595A patent/AR027398A1/es not_active Application Discontinuation
2002
- 2002-08-09 NO NO20023770A patent/NO20023770L/no not_active Application Discontinuation
- 2002-09-10 ZA ZA200207273A patent/ZA200207273B/en unknown

Also Published As

Publication number	Publication date
HK1051863A1 (en)	2003-08-22
AR027398A1 (es)	2003-03-26
CO5261548A1 (es)	2003-03-31
BR0108154A (pt)	2003-01-21
AU3166401A (en)	2001-08-20
ATE293620T1 (de)	2005-05-15
ECSP013923A (es)	2002-09-27
AU2001231664B2 (en)	2006-02-23
KR20020073585A (ko)	2002-09-27
US20030045728A1 (en)	2003-03-06
AU2001231664C1 (en)	2006-10-05
IL151154A0 (en)	2003-04-10
WO2001058893A2 (de)	2001-08-16
EP1254133A2 (de)	2002-11-06
RU2002123332A (ru)	2004-01-10
SK11152002A3 (sk)	2003-01-09
WO2001058893A3 (de)	2002-04-18
PL356427A1 (en)	2004-06-28
CN1398264A (zh)	2003-02-19
CA2399813C (en)	2010-03-09
DE50105955D1 (de)	2005-05-25
NO20023770D0 (no)	2002-08-09
EP1254133B1 (de)	2005-04-20
CA2399813A1 (en)	2001-08-16
JP2003530319A (ja)	2003-10-14
JP4938194B2 (ja)	2012-05-23
US6743810B2 (en)	2004-06-01
ES2240400T3 (es)	2005-10-16
CN1214026C (zh)	2005-08-10
CZ20022616A3 (cs)	2002-10-16
EP1254133B9 (de)	2005-09-07
RU2257380C2 (ru)	2005-07-27
NZ521260A (en)	2004-02-27
DE10006139A1 (de)	2001-08-16
HUP0302671A2 (hu)	2003-12-29
MXPA02007732A (es)	2002-10-11
PT1254133E (pt)	2005-09-30
PE20011125A1 (es)	2001-11-07
ZA200207273B (en)	2003-12-10

Publication	Publication Date	Title
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
NO20024766L (no)	2002-11-28	Etylendiaminderivater
NO20023770L (no)	2002-08-09	Indol-3-ylderivater
ATE540013T1 (de)	2012-01-15	Naphthalinderivate
NO20025590L (no)	2002-11-21	Fenylglycin-derivater
ATE288437T1 (de)	2005-02-15	Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
ATE414056T1 (de)	2008-11-15	Substituierte c-cyclohexylmethylamin-derivative
AR028602A1 (es)	2003-05-14	Derivados de pirrol
AR028282A1 (es)	2003-04-30	Derivados de aminofenil pirimidona
ATE282021T1 (de)	2004-11-15	Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
PT1351959E (pt)	2005-09-30	Novos derivados de pleuromutilina
ATE403646T1 (de)	2008-08-15	Aminocyclohexan-derivate
ATE280752T1 (de)	2004-11-15	Aminomethyl-phenyl-cyclohexanonderivate
DE60117096D1 (de)	2006-04-20	Dihydroindol- und tetrahydrochinolinderivate
DE50112454D1 (de)	2007-06-14	Substituierte 5-amino-1-penten-3-ol-derivate
DE60118970D1 (de)	2006-05-24	Indol- und dihydroindolderivate
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater
DE50104434D1 (de)	2004-12-09	Lactam-substituierte pyrazolopyridinderivate
DK1246793T3 (da)	2005-02-21	Substituerede aminomethyl-phenyl-cyclohexanderivater
DOP2000000093A (es)	2002-03-30	Derivados de benzamina
DK1305307T3 (da)	2004-08-09	Indolderivater

Legal Events

Date	Code	Title	Description
2004-12-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application